In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Ludwika PiwowarczykPoznan University of Medical Sciences, Department of Pharmaceutical Chemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0002-0888-7262 Jagoda SzkudlarekPoznan University of Medical Sciences, Department of Pharmaceutical Chemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0009-0005-4283-2133 Dariusz T MlynarczykPoznan University of Medical Sciences, Department of Chemical Technology of Drugs, Rokietnicka 3, 60-803 Poznan, Poland.ORCID 0000-0003-3583-0752 Szymon TomczakPoznan University of Medical Sciences, Department of Pharmaceutical Chemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0001-6130-7522 Violetta Krajka-KuźniakPoznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0001-7275-0298 Aleksandra Majchrzak-CelińskaPoznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0002-2872-8875 Robert KleszczPoznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0002-6607-7436 Ewelina MusielakPoznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0003-0683-4631 Mateusz de MezerPoznan University of Medical Sciences, Department of Immunobiology, Rokietnicka 8, 60-806 Poznan, Poland.ORCID 0000-0003-4718-9747 Gabriela AnglartPoznan University of Medical Sciences, Department of Pharmaceutical Chemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0001-8231-3526 Anna JelińskaPoznan University of Medical Sciences, Department of Pharmaceutical Chemistry, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0002-3019-5844 Funding
Medical Research Agency of Poland 2024/ABM/03/KPO/KPOD.07.07-IW.07-0043/24-00
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
20-hydroxyecdysoneDanio reriodrug delivery systemskeratinocytesniosomespsoriasis
Identifiers
PMID42797271
PMCPMC13610785
What OpenQuestion holds
Textmetadata
Read underepoch 390